-
EP2181705
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2181705
| EP2181705 - Sustained-release formulation of gliclazide [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.05.2011 Database last updated on 15.06.2024 | Most recent event Tooltip | 13.05.2011 | Application deemed to be withdrawn | published on 15.06.2011 [2011/24] | Applicant(s) | For all designated states Disphar International B.V. Winkelskamp 6 7255 PZ Hengelo / NL | [2010/18] | Inventor(s) | 01 /
Wit, Johannes Bernardus, Maria Horizon 27 3742 ZD Baarn / NL | 02 /
Doshi, Hiteshkumar Anilkant B-104 Wilowws Twin Tower Near Swapna Nagari Off. L.B.S. marg Mulund (W), Mumbai 400 080 / IN | [2010/18] | Representative(s) | Hirsch & Associés 154 Boulevard Haussmann 75008 Paris / FR | [N/P] |
| Former [2010/18] | Hirsch & Associés 58, avenue Marceau 75008 Paris / FR | Application number, filing date | 08291018.3 | 31.10.2008 | [2010/18] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2181705 | Date: | 05.05.2010 | Language: | EN | [2010/18] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 08.04.2009 | Classification | IPC: | A61K9/16, A61K9/20, A61K31/64 | [2010/18] | CPC: |
A61K9/2054 (EP);
A61K31/64 (EP);
A61K9/2077 (EP);
A61K9/1611 (EP)
| Designated contracting states | [2011/02] |
| Former [2010/18] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | Gliclazid-Formulierung mit verlängerter Freisetzung | [2010/18] | English: | Sustained-release formulation of gliclazide | [2010/18] | French: | Formulation à libération prolongée de gliclazide | [2010/18] | Examination procedure | 06.11.2010 | Application deemed to be withdrawn, date of legal effect [2011/24] | 23.12.2010 | Despatch of communication that the application is deemed to be withdrawn, reason: examination fee not paid in time [2011/24] | Fees paid | Penalty fee | Additional fee for renewal fee | 31.10.2010 | 03 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2008062470 (TORRENT PHARMACEUTICALS LTD [IN], et al) [Y] 1-18 * examples 1,2 *; | [Y]WO2006123213 (RANBAXY LAB LTD [IN], et al) [Y] 1-18 * examples 1,2 *; | [X]WO2006035313 (AUROBINDO PHARMA LTD [IN], et al) [X] 16 * example 7 *; | [A] - ARNO E A ET AL, "EUDRAGIT NE30D BASED NETFORMIN/GLICLAZIDE EXTENDED RELEASE TABLETS: FORMULATION, CHARACTERISATION AND IN VITRO RELEASE STUDIES", CHEMICAL AND PHARMACEUTICAL BULLETIN, PHARMACEUTICAL SOCIETY OF JAPAN, TOKYO, (20021101), vol. 50, no. 11, ISSN 0009-2363, pages 1495 - 1498, XP001207838 [A] 1-18 * page 1495, paragraphs MATERIALS,AND,METHODS * * table 1 * DOI: http://dx.doi.org/10.1248/cpb.50.1495 | by applicant | US4056623 | EP0468392 | US4696815 | CA2173366 | WO9918932 | US6475521 | US6524618 | WO0018373 | WO2005009412 | WO2006123213 | WO2006061697 | WO2008062470 |